Serum Institute of India (SII) would require round Rs 3,000 crore to ramp up manufacturing capability for making vaccines for Covid-19, its CEO Adar Poonawalla stated on Tuesday.
“We need roughly Rs 3,000 crores which is not a small figure considering we have already spent thousands of crores. We have to find other innovative ways to build our capacity so we can support our nation in light of Covid surge,” Poonawalla stated in an interview to NDTV tweeted by the channel.
The firm hopes to extend its capability of Covishield to 110 million doses per thirty days from June onwards, he added.
The firm is producing 2 million doses per day, Poonawalla stated.
“We have delivered over 100 million doses to India alone and exported around 60 million doses to other countries,” he added.
Serum Institute together with different vaccine producers have agreed with the federal government to sacrifice income. There is not any vaccine trade on the planet that has agreed to offer vaccines at such a subsidised value, he added.
In one other interview to ET NOW, Poonawalla stated that Serum Institute is prioritising briefly wants of India earlier than others.
The firm at present has capability to supply 60 to 70 million doses per thirty days, he stated.
The vaccine trade has sacrificed thousands and thousands of {dollars} to help the nation, he added.
